Chimeric Therapeutics Ltd (CHM) — Financial Flexibility Index
Chimeric Therapeutics Ltd (CHM) has a Financial Flexibility Index of -0.43x as of December 2025. Free cash flow of AU$-3.84 Million (operating CF AU$-3.84 Million minus capex AU$5.00) represents 0% of total liabilities (AU$8.96 Million). Check CHM capital-intensive asset ratio to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Chimeric Therapeutics Ltd Financial Flexibility Index (2020–2025)
Historical Financial Flexibility Index trend for Chimeric Therapeutics Ltd across 6 annual periods. See Chimeric Therapeutics Ltd current assets vs equity to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Chimeric Therapeutics Ltd (2020–2025)
Year-by-year free cash flow to debt coverage for Chimeric Therapeutics Ltd. For the full company profile including market capitalisation, see Chimeric Therapeutics Ltd market cap and net worth.
| Year | Flexibility Index | Free Cash Flow (AUD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.37x | AU$-7.28 Million | AU$-7.28 Million | AU$19.60 Million | ▼ -47103.4% |
| 2024 | 0.00x | AU$10.11K | AU$-7.54 Million | AU$12.80 Million | ▲ +100.1% |
| 2023 | -0.97x | AU$-16.20 Million | AU$-16.32 Million | AU$16.71 Million | ▲ +29.5% |
| 2022 | -1.38x | AU$-12.62 Million | AU$-13.15 Million | AU$9.17 Million | ▼ -342.4% |
| 2021 | -0.31x | AU$-3.54 Million | AU$-8.84 Million | AU$11.37 Million | ▼ -12.1% |
| 2020 | -0.28x | AU$-17.75K | AU$-34.01K | AU$64.01K | — |